当前位置: X-MOL 学术J. Clin. Invest. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
The Journal of Clinical Investigation ( IF 15.9 ) Pub Date : 2023 , DOI: 10.1172/jci173510
Stephanie M Salabarria 1 , Manuela Corti 1 , Kirsten E Coleman 1 , Megan B Wichman 1 , Julie A Berthy 1 , Precilla D'Souza 2 , Cynthia J Tifft 2 , Roland W Herzog 3 , Melissa E Elder 1 , Lawrence R Shoemaker 1 , Carmen Leon-Astudillo 1 , Fatemeh Tavakkoli 4 , David H Kirn 4 , Jonathan D Schwartz 5 , Barry J Byrne 1
Affiliation  

BACKGROUND. Systemic administration of adeno-associated virus (AAV) can trigger life-threatening inflammatory responses, including thrombotic microangiopathy (TMA), acute kidney injury due to atypical hemolytic uremic syndrome–like complement activation, immune-mediated myocardial inflammation, and hepatic toxicity.

中文翻译:

全身 AAV 给药后的血栓性微血管病依赖于抗衣壳抗体

背景。腺相关病毒(AAV)的全身给药可引发危及生命的炎症反应,包括血栓性微血管病(TMA)、非典型溶血性尿毒症综合征样补体激活引起的急性肾损伤、免疫介导的心肌炎症和肝毒性。
更新日期:2024-01-03
down
wechat
bug